Instructions for Use

Learn the ABCs for helping patients take LONHALA® (glycopyrrolate) Inhalation Solution with MAGNAIR® Nebulizer System

Help patients remember the detailed steps for use located in the Patient Information, Quick Reference Guide, or Manufacturer's Instructions for Use by learning the ABCs. Patients should refer to the full Prescribing Information and Patient Information before using LONHALA MAGNAIR.

A

Assemble your device
before each use

B

Breathe in
medication naturally

C

Clean your device
after each use

 

Before you use LONHALA MAGNAIR for the first time, it is important to clean all the parts.

Replacement parts for the Handset (Handset body, Medication cap, Aerosol head, and Mouthpiece) will be provided with every LONHALA MAGNAIR Refill Kit.

Please discard the old Handset parts when you receive the Refill Kit.

 

1. Power the Controller.

Open the battery door

Lift black tab to open battery door.

Insert 4 AA batteries

Insert 4 AA batteries into Controller as shown and then close battery door.

Or plug in the AC adapter

Plug one end of AC adapter into the inlet on the black battery door and the other end into a wall outlet.

2. Insert Aerosol head.

Open top of handset body

Open top of Handset body.

Insert aerosol head

With the silver side facing up, insert Aerosol head into Handset body as shown.

Do Not touch the center of the Aerosol head.

Open top of handset body

Close the Handset body. You may hear a “Click”.

3. Attach Mouthpiece.

Attach the mouthpiece to the handset

Attach the Mouthpiece to the Handset body. Make sure the Blue valve is pressed down.

4. Attach Connection cord.

Connect blue round end of connection cord

Connect blue round end of Connection cord into blue inlet of Controller until it “Clicks”.

Connect the controller to the handset body

Connect the Controller to the Handset body using the Connection cord as shown.

5. Open foil and separate vials.

Connect blue round end of connection cord

Open the foil pouch enough to remove the 2 LONHALA vials and separate them. Return 1 vial to the opened foil pouch and store in the Carrying bag to be used at your next treatment. Discard the vial if not used within 7 days.

6. Insert LONHALA vial and attach Medication cap.

Insert vial into medication cap

Insert LONHALA vial into bottom of Medication cap until it “Clicks”.

Connect the controller to the handset body

Make sure the Aerosol head is installed before attaching the Medication cap.

Place Medication cap with LONHALA vial on top of Handset body.

Turn Medication cap clockwise onto Handset body until it “Clicks”.

Do Not loosen or remove the Medication cap or unclasp the Handset body until treatment is complete.

 

7. Using LONHALA MAGNAIR

Insert mouthpiece into your mouth

Insert Mouthpiece into your mouth. Do not tilt Handset.

Press On/Off button on Controller to start treatment as shown.

Breathe in and out normally

Breathe in (inhale) and breathe out (exhale) normally through Mouthpiece. Treatment should take 2 to 3 minutes.

Controller will beep when treatment is complete

When treatment is complete, Controller will Beep twice and turn off.

Even if your treatment is taking longer than 3 minutes, continue until the Controller turns off.

Rinse and clean the Handset after use. Do Not leave the Aerosol head in the Handset.

 

Cleaning the Handset after each use helps maintain a 2 to 3 minute treatment time. Treatment can take longer if you do not clean the Handset.

 

8. Disassemble Handset.

Diassemble handset parts

Disassemble Handset parts in preparation for cleaning as shown.

Open Blue valve on Mouthpiece.

Remove LONHALA vial by placing Medication cap into the palm of your hand and pushing up.

Throw away the LONHALA vial into the wastebasket.

9. Rinse.

Keep aerosol head separate from other parts

Keep Aerosol head separate from other Handset parts and rinse each side well with warm running water for 10 seconds.

Rinse parts under warm water

Rinse each Handset part under warm running water for 10 seconds.

10. Wash.

Swish aerosol head in warm water

Hold the Aerosol head handle and swish it back and forth in the warm soapy water for 10 seconds.

Wash all parts in warm water

Wash all Handset parts in warm soapy water for 10 seconds.

11. Rinse.

Rinse aerosol head

Keep Aerosol head separate from other parts and rinse each side well with warm running water for 10 seconds.

Rinse all parts

Rinse each Handset part under warm running water for 10 seconds.

Inspect Handset parts to make sure they are completely clean. If any parts are still dirty, soak the parts for 5 more minutes. Rinse well with warm running water until the parts are clean.

12. Dry.

Shake parts to remove excess water

Shake each Handset part to remove excess water. Let parts air-dry on a lint-free towel.

13. Store disassembled Handset parts.

Store parts in carrying bag

After the Handset parts are completely dry, place in the Carrying bag or a dry, dust-free environment for storage.

Reassemble the Handset just prior to the next treatment. Do Not put the Handset parts back together until ready to use again for your next dose of LONHALA.

 

Reminder: Do Not clean your Handset parts with alcohol or put in the dishwasher, as this will damage the parts.

 

LONHALA solution is for oral inhalation only and should not be injected or swallowed. LONHALA vials should only be administered with MAGNAIR.

 

It is important for patients to understand how to correctly administer LONHALA vials using MAGNAIR. Instruct patients that LONHALA vials should only be administered via MAGNAIR and MAGNAIR should not be used for administering other medications. Patients should be instructed not to inject or swallow the LONHALA solution.

Instruct patients to store LONHALA vials in the sealed foil pouch and to only open the foil pouch to remove a LONHALA vial immediately before use. Inform patients that unopened vials should be returned to the opened foil pouch for use at their next treatment and discarded if not used within 7 days or it may not be as effective.

Inform patients to use one inhalation of LONHALA MAGNAIR orally twice daily (1 vial in the morning and 1 vial in the evening) at the same time every day.

Inform patients that if they miss a dose of LONHALA MAGNAIR, they should use their next vial at the usual time. Instruct patients to not use 2 vials at one time and to not use more than 2 vials in a day.

A Video Guide on How to Use LONHALA® MAGNAIR® (glycopyrrolate) Inhalation Solution


Can't see the video or want more detailed information? Read or download the Manufacturer's Instructions for Use, Quick Reference Guide, or Patient Information.

Important Safety Information & Indication 

Important Safety Information
 

LONHALA MAGNAIR is contraindicated in patients with a hypersensitivity to glycopyrrolate or to any of the ingredients.

LONHALA MAGNAIR should not be initiated in patients with acutely deteriorating or potentially life-threatening episodes of COPD or used as rescue therapy for acute episodes of bronchospasm. Acute symptoms should be treated with an inhaled short-acting beta2-agonist.

As with other inhaled medicines, LONHALA MAGNAIR can produce paradoxical bronchospasm that may be life-threatening. If paradoxical bronchospasm occurs following dosing with LONHALA MAGNAIR, it should be treated immediately with an inhaled, short-acting bronchodilator; LONHALA MAGNAIR should be discontinued immediately and alternative therapy instituted.

Immediate hypersensitivity reactions have been reported with LONHALA MAGNAIR. If signs occur, discontinue LONHALA MAGNAIR immediately and institute alternative therapy.

LONHALA MAGNAIR should be used with caution in patients with narrow-angle glaucoma and in patients with urinary retention. Prescribers and patients should be alert for signs and symptoms of acute narrow-angle glaucoma (e.g., eye pain or discomfort, blurred vision, visual halos or colored images in association with red eyes from conjunctival congestion and corneal edema) and of urinary retention (e.g., difficulty passing urine, painful urination), especially in patients with prostatic hyperplasia or bladder-neck obstruction. Patients should be instructed to consult a physician immediately should any of these signs or symptoms develop.

The most common adverse events reported in ≥2% of patients taking LONHALA MAGNAIR, and occurring more frequently than in patients taking placebo, were dyspnea (4.9% vs 3.0%) and urinary tract infection (2.1% vs 1.4%).

LONHALA solution is for oral inhalation only and should not be injected or swallowed. LONHALA vials should only be administered with MAGNAIR.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

For additional information, please see full Prescribing Information and Patient Information for LONHALA MAGNAIR at www.sunovionprofile.com/lonhala-magnair.


Indication
 

LONHALA® MAGNAIR® (glycopyrrolate) is an anticholinergic indicated for the long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.